Quebec, Your Destination of Choice for Accelerating Your Clinical Research Projects

"As an R&D driven global biopharma company focused on delivering an industry leading pipeline, Sanofi’s clinical trials in Quebec are an important catalyst in delivering first- and best-in-class medicines and vaccines to patients. CATALIS, the province’s coordinator of clinical research activities, possesses in-depth knowledge of regional health care partners and organizations that has enabled us to recruit patients and launch trials on an expedited basis. CATALIS has been instrumental in advancing Sanofi’s clinical trials in Quebec and delivering relevant data to optimally support product launches."

"Clinical trials are a vital part of Pfizer's mission to develop new treatments and improve patient care. Quebec is a leader in clinical trials. Its robust regulatory framework and diverse population enable the generation of clinical data of great importance to research. Pfizer is committed to conducting clinical trials here that reflect the diversity of the country's population and meet the highest regulatory standards. We are proud to work in partnership with healthcare institutions and professionals in Quebec to advance medical research and improve the health and well-being of patients across Canada. Through these efforts, we help accelerate access to innovative medicines while ensuring the quality of data collected and the speed of clinical development."

"Quebec is a true epicenter for the pharmaceutical sector and innovation. Bristol Myers Squibb established its foundation in Canada 100 years ago, and opened its first facilities in Quebec 70 years ago. From major breakthroughs in fundamental research at world-class universities to solid infrastructures for preclinical and clinical trials, the province offers an unmatched environment for health sciences. Quebec's leading academic and scientific institutions provide invaluable perspectives for clinical trials, which allow us to ensure that our therapies are effective for a wide range of patients. The integrated healthcare system also fosters a collaborative environment conducive to generating real-world evidence and supports the adoption of new therapeutic options. We don't just conduct our activities in Quebec; it's where we contribute to delivering life-changing medicines to Canadians, every day."

"Quebec plays a central role in Canada’s clinical research ecosystem and is making its mark on the global stage thanks to its expertise in artificial intelligence, biomedical sciences, and fundamental research. With an integrated public healthcare system that facilitates data access, a diverse population, and strong collaborations with key stakeholders, Quebec offers a fertile environment for health innovation. At GSK, we are proud to leverage these strengths to turn scientific discoveries into tangible advances for patients in Canada and around the world. Together, we are accelerating the development of innovative solutions to address today’s most pressing health challenges."

"The life sciences sector is an essential pillar of a strong and innovative economy, driving advancements in health, science, and economic development. At the heart of this ecosystem, clinical research plays a fundamental role by enabling the development of innovative treatments and ensuring a better future for patients. With its world-class researchers, leading institutions, industry expertise, and highly skilled workforce, Quebec is a leader in this field, both in Canada and internationally. At Roche Canada, we are proud to contribute to the province’s vitality by investing in research and innovation, fostering partnerships, and encouraging collaborations that enhance patient health and leave a lasting impact."